Full Text View
Tabular View
No Study Results Posted
Related Studies
Peptide-pulsed vs. RNA-transfected Dendritic Cell Vaccines in Melanoma Patients
This study has been completed.
Study NCT00243529   Information provided by Radboud University
First Received: October 21, 2005   Last Updated: September 28, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Melanoma Stage III or IV
Additional conditions recognized in this trial
Melanoma
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Germ Cell and Embryonal
Neoplasms, Nerve Tissue
Neuroectodermal Tumors
Neuroendocrine Tumors
Nevi and Melanomas
Interventions listed in this trial
autologous dendritic cell vaccine
Sponsors listed in this trial
Radboud University
Dutch Cancer Society


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services